<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To study the effects of a spin trap agent and a CD18 antibody administered after <z:hpo ids='HP_0001297'>stroke</z:hpo> induction on intracerebral hemorrhaging </plain></SENT>
<SENT sid="1" pm="."><plain>The drugs can prevent leukocyte <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A rabbit embolic <z:hpo ids='HP_0001297'>stroke</z:hpo> model that produces <z:hpo ids='HP_0001342'>intracerebral hemorrhage</z:hpo> was used </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: A time course study showed that hemorrhaging was grossly apparent in approximately 50% of the subjects at 5 hours and in 75% at 24 hours after embolization </plain></SENT>
<SENT sid="4" pm="."><plain>MDL 101,002, a spin trap agent, administered IV 5 minutes after embolization, significantly decreased the volume of <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>It also improved the behavior score relative to vehicle-treated rabbits </plain></SENT>
<SENT sid="6" pm="."><plain>The CD18 antibody tended to decrease <z:mp ids='MP_0001914'>hemorrhage</z:mp> volume </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: The beneficial effect of MDL 101,002 may be caused by inhibition of free radical injury to brain tissue, thereby protecting brain microvessel integrity </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> therapy for <z:hpo ids='HP_0001342'>intracerebral hemorrhage</z:hpo> may be feasible </plain></SENT>
</text></document>